Brief: Medincell's Partner Teva Presents Data From Phase 3 Of Olanzapine Lai

Medincell SA

23/09/2024 07:05

Sept 23 (Reuters) - Medincell SA  MEDCL.PA :
    * MEDINCELL'S PARTNER TEVA PRESENTED NEW EFFICACY, SAFETY,
AND
TOLERABILITY DATA FROM PIVOTAL PHASE 3 OF OLANZAPINE LAI

Source text for Workspace:  urn:newsml:reuters.com:*:nBw32Cvxxa
Further company coverage:  MEDCL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 785 110;))